Influenza vaccine regimens for pandemic-associated strains

Details for Australian Patent Application No. 2010212547 (hide)

Owner Novartis AG

Inventors Groth, Nicola; Fragapane, Elena

Agent FB Rice

Pub. Number AU-A-2010212547

PCT Pub. Number WO2010/092476

Priority 61/207,371 10.02.09 US

Filing date 10 February 2010

Wipo publication date 19 August 2010

International Classifications

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

Event Publications

1 September 2011 PCT application entered the National Phase

  PCT publication WO2010/092476 Priority application(s): WO2010/092476

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212548-Influenza vaccines with increased amounts of H3 antigen

2010212543-Process for maximizing PHA production in glycogen accumulating organisms